Assertio Holdings (ASRT) Other financing activities (2022 - 2023)
Assertio Holdings' (ASRT) quarterly Other financing activities came in at $458000.0 in Q4 2023, down 90.28% year-on-year from $4.7 million in Q4 2022, and down 90.28% quarter-over-quarter from $4.7 million in Q4 2022.
Assertio Holdings (ASRT) Other financing activities (2022 - 2023) Analysis & Trends
Assertio Holdings has disclosed Other financing activities across 2 years of filings, most recently posting $458000.0 for Q4 2023.
- Other financing activities for Q4 2023 came in at $458000.0, down 90.28% year-over-year; the trailing twelve-month figure through Dec 2024 was $5.2 million (changed 0.0% YoY), and the FY2023 annual result was -$31000.0, down 100.76% from the prior year.
- Other financing activities came in at $458000.0 for Q4 2023 at Assertio Holdings, down from $4.7 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $4.7 million in Q4 2022 to a low of $458000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 458,000.00 |
| Dec 31, 2023 | 458,000.00 |
| Dec 31, 2022 | 4.71 Mn |
| Dec 31, 2022 | 4.71 Mn |